Remove 2001 Remove Doctors Remove Pharmaceuticals Remove Treatment
article thumbnail

Chipscreen and HISUN reach a strategic cooperation

The Pharma Data

(hereinafter referred to as: CHIPSCREEN BIOSCIENCES) and ZHEJIANG HISUN PHARMACEUTICAL CO., hereinafter referred to as: HISUN PHARMACEUTICAL) announced that they have reached a strategic cooperation. This cooperation intends to quickly provide to Chinese patients with this innovative diabetes treatment mechanism.

article thumbnail

What to expect from PEGS Europe 2023: Day 2

Drug Discovery World

Alessa Schaffrath, Doctoral Student, UKE Hamburg, on: ‘Transgenic llama mice – a fast and flexible single domain discovery tool’. Sandra Ergueta-Carballo, PhD, Project Coordinator, University of Cambridge, on: ‘Advancing snake envenomation treatment: designing the next generation of antivenoms’.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Another Update on Medical Abortion Litigation

Drug & Device Law

341 (2001), is so important. They “must participate in the medical treatment that facilitates” something they don’t like. “[T]reating The Doctors therefore sustain a concrete injury when they are forced to divert time and resources away from their regular patients. That’s why Buckman Co. Plaintiffs Legal Committee , 531 U.S.

FDA 52
article thumbnail

Another Update on Medical Abortion Litigation

Drug & Device Law

341 (2001), is so important. They “must participate in the medical treatment that facilitates” something they don’t like. “[T]reating The Doctors therefore sustain a concrete injury when they are forced to divert time and resources away from their regular patients. That’s why Buckman Co. Plaintiffs Legal Committee , 531 U.S.

article thumbnail

CPAP MDL Overinflates Plaintiffs’ Claims

Drug & Device Law

Abuse of substantive law as a weapon to force settlement occurs so frequently in multidistrict litigation (“MDL”), that we’ve given it a name – “the MDL treatment.” The linchpin of the MDL treatment is that plaintiffs are allowed to take way more liberties with state law than the Erie doctrine allows. Senju Pharmaceutical Co. ,

article thumbnail

Another RICOdiculous Decision

Drug & Device Law

We’ve discussed recently how a federal statute intended to allow suits against international terrorists has been misapplied as allowing suits against pharmaceutical companies. Takeda Pharmaceuticals Co. , 341 (2001). Takeda Pharmaceutical Co. , 3d 1243 (9th Cir. Plaintiffs Legal Committee , 531 U.S. PATDC82 I , 943 F.3d

article thumbnail

Confident Learned Intermediaries Defeat Warning Causation

Drug & Device Law

Thus a confident learned intermediary’s testimony will defeat causation as a matter of law by stating that, notwithstanding a poor result, the treatment provided was standard of care, and even in hindsight they would not do anything different. Bayer HealthCare Pharmaceuticals, Inc. , Wyeth Pharmaceuticals , 526 F.3d